Cargando…
Pirfenidone Improves Familial Idiopathic Pulmonary Fibrosis without Affecting Serum Periostin Levels
Background: Antifibrotic agents have been approved for the treatment of idiopathic pulmonary fibrosis (IPF). However, the efficacy of these drugs in the treatment of familial IPF (FIPF) has not been previously reported. Case presentation: We report the case of a 77-year-old man with FIPF, successful...
Autores principales: | Koga, Yasuhiko, Hachisu, Yoshimasa, Tsurumaki, Hiroaki, Yatomi, Masakiyo, Kaira, Kyoichi, Ohta, Shoichiro, Ono, Junya, Izuhara, Kenji, Dobashi, Kunio, Hisada, Takeshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6572615/ https://www.ncbi.nlm.nih.gov/pubmed/31108995 http://dx.doi.org/10.3390/medicina55050161 |
Ejemplares similares
-
Treatment with Tumor Necrosis Factor-α Inhibitors, History of Allergy, and Hypercalcemia Are Risk Factors of Immune Reconstitution Inflammatory Syndrome in HIV-Negative Pulmonary Tuberculosis Patients
por: Hachisu, Yoshimasa, et al.
Publicado: (2019) -
The Relationship between Tumor Development and Sarcoidosis in Aspects of Carcinogenesis before and after the Onset of Sarcoidosis
por: Hachisu, Yoshimasa, et al.
Publicado: (2022) -
The Onset of Eosinophilic Pneumonia Preceding Anti-synthetase Syndrome
por: Hachisu, Yoshimasa, et al.
Publicado: (2017) -
17(R)‐resolvin D1 ameliorates bleomycin‐induced pulmonary fibrosis in mice
por: Yatomi, Masakiyo, et al.
Publicado: (2015) -
Using Periostin as a Biomarker in the Treatment of Asthma
por: Izuhara, Kenji, et al.
Publicado: (2016)